Use of respiratory medication in five Latin American cities: The PLATINO study

Simple item page
dc.contributor.authorde Oca, Maria Montes
dc.contributor.authorTalamo, Carlos
dc.contributor.authorPerez Padilla, Rogelio
dc.contributor.authorLopez, Maria Victorina
dc.contributor.authorMuino, Adriana
dc.contributor.authorJardim, Jose Roberto B.
dc.contributor.authorValdivia, Gonzalo
dc.contributor.authorPertuze, Julio
dc.contributor.authorMoreno, Dolores
dc.contributor.authorHalbert, Ronald J.
dc.contributor.authorMenezes, Ana Maria B.
dc.contributor.authorPLATINO Team
dc.date.accessioned2024-01-10T14:22:22Z
dc.date.available2024-01-10T14:22:22Z
dc.date.issued2008
dc.description.abstractBackground: There is scanty information regarding respiratory medication prescription pattern in Latin America. We examined the use of bronchodilators and corticosteroids in a population-based study conducted in five Latin American cities.
dc.description.abstractMethods: Medication use was derived from questions regarding the use of medication "to help breathing" within the previous 12 months, type of medicine, and frequency of use. To minimize the possibility of overdiagnosis, we used postbronchodilator FEV1/FVC < 0.70 plus FEV1 < 80% as the definition of obstruction.
dc.description.abstractResults: Interviews were completed in 5571 subjects from 6711 eligible individuals, and spirometry was performed in 5314 subjects. There were 360 (6.5%) treated subjects and 5211 not treated. Treated subjects were more likely to be older, women, unemployed, have higher tobacco consumption, higher body mass index, higher FEV, reversibility and airway obstruction. They were also more likely to report prior spirometry, prior diagnosis of COPD, asthma or tuberculosis, and more respiratory symptoms. Over half of treated subjects had neither obstruction nor FEV, reversibility, and approximately 30% reported no prior diagnosis of asthma or COPD. Prior respiratory diagnoses and wheezing were more strongly associated with treatment than objective measures of airway obstruction.
dc.description.abstractConclusions: The use of bronchodilators and/or corticosteroids is common in the general population aged 40 years or older, with over one-half of treated subjects using them without being obstructed. (c) 2008 Elsevier Ltd. All rights reserved.
dc.description.funderAsociacion Latinoamericana de Torax (ALAT)
dc.description.funderBoehringer Ingelheim GmbH
dc.fechaingreso.objetodigital08-04-2024
dc.format.extent6 páginas
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.pupt.2008.06.003
dc.identifier.issn1094-5539
dc.identifier.pubmedidMEDLINE:18621136
dc.identifier.urihttps://doi.org/10.1016/j.pupt.2008.06.003
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/79921
dc.identifier.wosidWOS:000262944200012
dc.information.autorucMedicina;Pertuze J;S/I;99166
dc.information.autorucMedicina;Valdivia G;S/I;57007
dc.issue.numero5
dc.language.isoen
dc.nota.accesoContenido parcial
dc.pagina.final793
dc.pagina.inicio788
dc.publisherACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
dc.revistaPULMONARY PHARMACOLOGY & THERAPEUTICS
dc.rightsacceso restringido
dc.subjectBronchodilators
dc.subjectChronic obstructive pulmonary disease
dc.subjectEpidemiology
dc.subjectPrevalence
dc.subjectSteroids
dc.subjectOBSTRUCTIVE PULMONARY-DISEASE
dc.subjectGLOBAL BURDEN
dc.subjectLUNG-FUNCTION
dc.subjectPRIMARY-CARE
dc.subjectPREVALENCE
dc.subjectCOPD
dc.subjectPOPULATION
dc.subjectDIAGNOSIS
dc.subjectASTHMA
dc.subjectADULTS
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleUse of respiratory medication in five Latin American cities: The PLATINO study
dc.typeartículo
dc.volumen21
sipa.codpersvinculados99166
sipa.codpersvinculados57007
sipa.indexWOS
sipa.indexScopus
sipa.trazabilidadCarga SIPA;09-01-2024
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
2024-04-08. Use of respiratory medication in five Latin American cities - The PLATINO study.pdf
Size:
3.14 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas